← Product Code [JIL](/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/JIL) · K061812

# COMBI SCAN 500 URINE TEST STRIP ANALYZER, MODEL A93005 (K061812)

_Analyticon Biotechnologies AG · JIL · Apr 6, 2007 · Clinical Chemistry · SESE_

**Canonical URL:** https://fda.innolitics.com/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/JIL/K061812

## Device Facts

- **Applicant:** Analyticon Biotechnologies AG
- **Product Code:** [JIL](/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/JIL.md)
- **Decision Date:** Apr 6, 2007
- **Decision:** SESE
- **Submission Type:** Traditional
- **Regulation:** 21 CFR 862.1340
- **Device Class:** Class 2
- **Review Panel:** Clinical Chemistry
- **Attributes:** 3rd-Party Reviewed

## Indications for Use

The Combi Scan 500 is for use with Combi Screen test strips to determine the following parameters from urine: ascorbic acid, bilirubin, blood, glucose, ketones, leucocytes, nitrite, pH, protein, specific gravity, urobilinogen. These measurements are used in the evaluation of diabetes, liver diseases, haemolytic diseases, urogenital and kidney disorders or metabolic abnormalities. For professional use only, not for self testing!

## Device Story

Combi Scan 500 is a bench-top automated urine analyzer for professional use. It processes urine-dipped Combi Screen test strips; user places strip on conveyor; instrument controls incubation time and performs reflectometric measurement of light reflected from test pads. Data converted into results; stored (up to 999 measurements); printed via internal thermal printer. Provides objective analysis of urine chemistry to assist clinicians in evaluating metabolic, renal, and hepatic conditions.

## Clinical Evidence

No clinical data provided; substantial equivalence based on bench testing and comparison of technological characteristics to the predicate device.

## Technological Characteristics

Benchtop instrument; reflectometric measurement principle using white light illumination and color CCD sensor. Dimensions/form factor: benchtop. Connectivity: internal thermal printer, manual/barcode/keyboard input. Power: 100-240V AC. Software: automated image processing and data management. No specific material standards cited.

## Regulatory Identification

A urinary glucose (nonquantitative) test system is a device intended to measure glucosuria (glucose in urine). Urinary glucose (nonquantitative) measurements are used in the diagnosis and treatment of carbohydrate metabolism disorders including diabetes mellitus, hypoglycemia, and hyperglycemia.

## Predicate Devices

- Clinitec 50 ([K960546](/device/K960546.md))

## Submission Summary (Full Text)

> This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com.
>
> Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/).

{0}

1

# 510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY ASSAY AND INSTRUMENT COMBINATION TEMPLATE

A. 510(k) Number:
k061812

B. Purpose for Submission:
New device for combination with Analyticon CombiScreen 11SYS Urine test strips (k023885)

C. Measurand:
Ascorbic acid, bilirubin, blood, glucose, ketones, leukocytes, nitrite, pH, protein, specific gravity, and urobilinogen in urine

D. Type of Test:
Qualitative / Semi-quantitative

E. Applicant:
Analyticon Biotechnologies AG

F. Proprietary and Established Names:
Combi Scan 500

G. Regulatory Information:

1. Regulation section:
21CFR§862.1340 Urinary glucose (nonquant.) test system
21CFR§862.6550 Occult blood test
21CFR§862.1095 Ascorbic acid test
21CFR§862.1115 Urinary bilirubin and its conjugates (nonquant.) test system
21CFR§862.1435 Ketones (nonquant.) test system
21CFR§862.1510 Nitrite (nonquant.) test system
21CFR§862.1550 Urinary ph (nonquant.) test system
21CFR§862.1645 Urinary protein or albumin (nonquant.) test system
21CFR§862.1785 Urinary urobilinogen (nonquant.) test system
21CFR§862.7675 Leukocyte peroxidase (nonquant.) test system
21CFR§862.2900 Automated Urine Analyzer

2. Classification:
Class II

{1}

3. Product code:
JIL - method, enzymatic, glucose (urinary, non-quantitative)
JIO - blood, occult, colorimetric, in urine
JMA - acid, ascorbic, 2,4-dinitrophenylhydrazine (spectrophotometric)
JJB - azo-dyes, colorimetric, bilirubin & its conjugates (urinary, non-quant.)
JIN - nitroprusside, ketones (urinary, non-quant.)
JMT - diazo (colorimetric), nitrite (urinary, non-quant.)
CEN - dye-indicator, ph (urinary, non-quant.)
JIR - indicator method, protein or albumin (urinary, non-quant.)
CDM - diazonium colorimetry, urobilinogen (urinary, non-quant.)
LJX - test, urine leukocyte
KQO - automated urinalysis system

4. Panel:
75 - Clinical chemistry

H. Intended Use:
1. Intended use(s):
See Indication(s) for use below.
2. Indication(s) for use:
The Combi Scan 500 is for use with Combi Screen test strips to determine the following parameters from urine: ascorbic acid, bilirubin, blood, glucose, ketones, leucocytes, nitrite, pH, protein, specific gravity, urobilinogen. These measurements are used in the evaluation of diabetes, liver diseases, haemolytic diseases, urogenital and kidney disorders or metabolic abnormalities. For professional use only, not for self testing!
3. Special conditions for use statement(s):
For prescription use
4. Special instrument requirements:
Analytic Combi Scan 500

I. Device Description:
The device is a small benchtop instrument designed to read the Combi Screen® 11SYS reagent strips. The Combi Scan® 500 urine analyzer supports test data management and report generation by offering data storage and computerised data processing features. The operator places the moisturized strip on the strip holder and presses the start button. The reading and printing is done by the device.

{2}

J. Substantial Equivalence Information:

1. Predicate device name(s):
Bayer Clinitek 50 Urine Chemistry Analyzer

2. Predicate 510(k) number(s):
k960546

3. Comparison with predicate:

|  Feature | Combi Scan 500 | Clinitek 50  |
| --- | --- | --- |
|  Intended use | Instrument for measurement of urine test strips Combi Screen for in-vitro determination of Ascorbic acid, Bilirubin, Blood, Glucose, Ketones, Leukocytes, Nitrite, pH, Protein, Specific Gravity, and Urobilinogen from urine. For professional use, not for self testing. | The Clinitek 50 urine chemistry analyser is for use with Bayer reagent strips for the determination of glucose, bilirubin, ketone, blood, protein, urobilinogen, nitrite and leucocytes in urine, urine pH, specific gravity and colour.  |
|  General design | Bench-top instrument | Bench-top instrument  |
|  Energy source | Power transformer Input: 100 - 240 V, 50/60 Hz Output. 7,5V, 3,0 A | Power transformer Input: 100 - 250 V, 50/60 Hz Output. 9V, 2,78 A  |
|  Measurement technology | The instrument measures the color of the light that is reflected from the test pads on the strip (reflectometric measurement). These data are converted into meaningful results. | The instrument measures the color and amount of light that is reflected from the test pads on the strip (reflectometric measurement). It then converts these measurements to meaningful results.  |
|  Measuring operation | The test strip is dipped into the urine and placed on the black strip holder, which moves the strip into the instrument. The instrument controls the incubation time and does the measurement. | The test strip is dipped into the urine and placed on the strip holder in front of the instrument. Then, the strip holder is moved into the instrument, which controls the incubation time and does the measurement.  |
|  Analytes | Test strip Combi Screen 11SYS: Ascorbic acid, Bilirubin, Blood, Glucose, Ketones, Leukocytes, Nitrite, pH, Protein, Specific Gravity, and Urobilinogen from urine. | Test strip Multistix 10SG: Bilirubin, Blood, Glucose, Ketones, Leukocytes, Nitrite, pH, Protein, Specific Gravity, and Urobilinogen from urine.  |

{3}

|  Feature | Combi Scan 500 | Clinitek 50  |
| --- | --- | --- |
|  Controlling of the system | LCD-Display, buttons below the display to control the instrument. | LCD-Display, buttons below the display to control the instrument.  |
|  Individual adjustments | SI/Conventional/Arbitrary unitsDate and time test sequence in printout | SI/Conventional/Arbitrary unitsDate and time  |
|  Storage of results | Storage of 999 measurements possible | Storage of measurements possible  |
|  Printing of results | Printout with results, date & time on thermal paper by internal printer | Printout with results, date & time on thermal paper by internal printer  |
|  Operating range | 15 - 30 °C<85% rel. humidity | 18 - 30 °C20 - 85% rel. humidity  |

# K. Standard/Guidance Document Referenced (if applicable):

CLSI Guideline EP12A, User Protocol for Evaluation of Qualitative Test Performance.

# L. Test Principle:

When a strip is moved into the measuring position under the optical unit, the test strip is illuminated by white light and the reflected light from the reagent strip is detected by a colour CCD sensor. The picture, which has been taken by the CCD camera, is evaluated and the result is divided into values for the red, green and blue colour for each test pad. Afterwards, these RGB-values are used in mathematical algorithms to transform them into a meaningful concentration for the user.

# M. Performance Characteristics (if/when applicable):

# 1. Analytical performance:

a. Precision/Reproducibility:

To evaluate the performance of the system, the following evaluations were carried out:

1) precision within-series (20 measurements with one lot/one instrument)
2) precision lot-to-lot (10 measurements with three lots/one instrument)
3) precision instrument-to-instrument (10 measurements with three instruments/one lot)

The precision was evaluated by using the urine dipstick control by

{4}

Quantimetrix. It is available as a 2 level set (level 1: normal, level 2: abnormal). The Quantimetrix dipstick control does not contain ascorbic acid. Therefore, the ascorbic acid test pad performance was evaluated by using human pool urine: a) negative, b) positive=spiked with 20 mg/dL ascorbic acid. The results are presented below.

1) Precision within-series

|  ASC* | Reference  |   |   |   |
| --- | --- | --- | --- | --- |
|  Combi Scan 500 |  | positive | negative | total  |
|   |  positive | 20 | 0 | 20  |
|   |  negative | 0 | 20 | 20  |
|   |  total | 20 | 20 | 40  |

* determined with human pool urine

|  BIL | Reference  |   |   |   |
| --- | --- | --- | --- | --- |
|  Combi Scan 500 |  | positive | negative | total  |
|   |  positive | 20 | 0 | 20  |
|   |  negative | 0 | 20 | 20  |
|   |  total | 20 | 20 | 40  |
|  LED | Reference  |   |   |   |
| --- | --- | --- | --- | --- |
|  Combi Scan 500 |  | positive | negative | total  |
|   |  positive | 20 | 0 | 20  |
|   |  negative | 0 | 20 | 20  |
|   |  total | 20 | 20 | 40  |
|  GLU | Reference  |   |   |   |
| --- | --- | --- | --- | --- |
|  Combi Scan 500 |  | positive | negative | total  |
|   |  positive | 20 | 0 | 20  |
|   |  negative | 0 | 20 | 20  |
|   |  total | 20 | 20 | 40  |
|  KET | Reference  |   |   |   |
| --- | --- | --- | --- | --- |
|  Combi Scan 500 |  | positive | negative | total  |
|   |  positive | 20 | 0 | 20  |
|   |  negative | 0 | 20 | 20  |
|   |  total | 20 | 20 | 40  |
|  pH | 5 | 6 | 7 | 8 | 9  |
| --- | --- | --- | --- | --- | --- |
|  Level 1 | 20 | - | - | - | -  |
|  Level 2 | - | - | 14 | 6 | -  |
|  SG | 1.000 | 1.005 | 1.010 | 1.015 | 1.020 | 1.025 | 1.030  |
| --- | --- | --- | --- | --- | --- | --- | --- |
|  Level 1 | - | - | - | 4 | 15 | 1 | -  |
|  Level 2 | - | 4 | 16 | - | - | - | -  |

{5}

6

2) Precision lot-to-lot

|  ASC* | Reference  |   |   |   |
| --- | --- | --- | --- | --- |
|  Combi Scan 500 |  | positive | negative | total  |
|   |  positive | 30 | 0 | 30  |
|   |  negative | 0 | 30 | 30  |
|   |  total | 30 | 30 | 60  |

* determined with human pool urine

|  BIL | Reference  |   |   |   |
| --- | --- | --- | --- | --- |
|  Combi Scan 500 |  | positive | negative | total  |
|   |  positive | 30 | 0 | 30  |
|   |  negative | 0 | 30 | 30  |
|   |  total | 30 | 30 | 60  |
|  BLD | Reference  |   |   |   |
| --- | --- | --- | --- | --- |
|  Combi Scan 500 |  | positive | negative | total  |
|   |  positive | 30 | 0 | 30  |
|   |  negative | 0 | 30 | 30  |
|   |  total | 30 | 30 | 60  |
|  GLU | Reference  |   |   |   |
| --- | --- | --- | --- | --- |
|  Combi Scan 500 |  | positive | negative | total  |
|   |  positive | 30 | 0 | 30  |
|   |  negative | 0 | 30 | 30  |
|   |  total | 30 | 30 | 60  |
|  KET | Reference  |   |   |   |
| --- | --- | --- | --- | --- |
|  Combi Scan 500 |  | positive | negative | total  |
|   |  positive | 30 | 0 | 30  |
|   |  negative | 0 | 30 | 30  |
|   |  total | 30 | 30 | 60  |
|  pH | 5 | 6 | 7 | 8 | 9  |
| --- | --- | --- | --- | --- | --- |
|  Level 1 | 30 | - | - | - | -  |
|  Level 2 | - | - | 3 | 27 | -  |
|  SG | 1.000 | 1.005 | 1.010 | 1.015 | 1.020 | 1.025 | 1.030  |
| --- | --- | --- | --- | --- | --- | --- | --- |
|  Level 1 | - | - | - | 11 | 19 | - | -  |
|  Level 2 | - | 1 | 29 | - | - | - | -  |
|  LEU | Reference  |   |   |   |
| --- | --- | --- | --- | --- |
|  Combi Scan 500 |  | positive | negative | total  |
|   |  positive | 30 | 0 | 30  |
|   |  negative | 0 | 30 | 30  |
|   |  total | 30 | 30 | 60  |
|  NIT | Reference  |   |   |   |
| --- | --- | --- | --- | --- |
|  Combi Scan 500 |  | positive | negative | total  |
|   |  positive | 30 | 0 | 30  |
|   |  negative | 0 | 30 | 30  |
|   |  total | 30 | 30 | 60  |
|  PRO | Reference  |   |   |   |
| --- | --- | --- | --- | --- |
|  Combi Scan 500 |  | positive | negative | total  |
|   |  positive | 30 | 0 | 30  |
|   |  negative | 0 | 30 | 30  |
|   |  total | 30 | 30 | 60  |
|  UBG | Reference  |   |   |   |
| --- | --- | --- | --- | --- |
|  Combi Scan 500 |  | positive | negative | total  |
|   |  positive | 30 | 0 | 30  |
|   |  negative | 0 | 30 | 30  |
|   |  total | 30 | 30 | 60  |

{6}

7

3) Precision instrument-to-instrument

|  ASC* | Reference  |   |   |   |
| --- | --- | --- | --- | --- |
|  Combi Scan 500 |  | positive | negative | total  |
|   |  positive | 30 | 0 | 30  |
|   |  negative | 0 | 30 | 30  |
|   |  total | 30 | 30 | 60  |

* determined with human pool urine

|  BIL | Reference  |   |   |   |
| --- | --- | --- | --- | --- |
|  Combi Scan 500 |  | positive | negative | total  |
|   |  positive | 30 | 0 | 30  |
|   |  negative | 0 | 30 | 30  |
|   |  total | 30 | 30 | 60  |
|  BLD | Reference  |   |   |   |
| --- | --- | --- | --- | --- |
|  Combi Scan 500 |  | positive | negative | total  |
|   |  positive | 30 | 0 | 30  |
|   |  negative | 0 | 30 | 30  |
|   |  total | 30 | 30 | 60  |
|  GLU | Reference  |   |   |   |
| --- | --- | --- | --- | --- |
|  Combi Scan 500 |  | positive | negative | total  |
|   |  positive | 30 | 0 | 30  |
|   |  negative | 0 | 30 | 30  |
|   |  total | 30 | 30 | 60  |
|  KET | Reference  |   |   |   |
| --- | --- | --- | --- | --- |
|  Combi Scan 500 |  | positive | negative | total  |
|   |  positive | 30 | 0 | 30  |
|   |  negative | 0 | 30 | 30  |
|   |  total | 30 | 30 | 60  |
|  pH | 5 | 6 | 7 | 8 | 9  |
| --- | --- | --- | --- | --- | --- |
|  Level 1 | 30 | - | - | - | -  |
|  Level 2 | - | - | 6 | 24 | -  |
|  SG | 1.000 | 1.005 | 1.010 | 1.015 | 1.020 | 1.025 | 1.030  |
| --- | --- | --- | --- | --- | --- | --- | --- |
|  Level 1 | - | - | - | 10 | 20 | - | -  |
|  Level 2 | - | 22 | 8 | - | - | - | -  |
|  LEU | Reference  |   |   |   |
| --- | --- | --- | --- | --- |
|  Combi Scan 500 |  | positive | negative | total  |
|   |  positive | 30 | 30 | 30  |
|   |  negative | 0 | 30 | 30  |
|   |  total | 30 | 60 | 60  |
|  NIT | Reference  |   |   |   |
| --- | --- | --- | --- | --- |
|  Combi Scan 500 |  | positive | negative | total  |
|   |  positive | 30 | 30 | 60  |
|   |  negative | 0 | 30 | 60  |
|   |  total | 30 | 30 | 60  |
|  PRO | Reference  |   |   |   |
| --- | --- | --- | --- | --- |
|  Combi Scan 500 |  | positive | negative | total  |
|   |  positive | 30 | 0 | 30  |
|   |  negative | 0 | 30 | 30  |
|   |  total | 30 | 30 | 60  |
|  UBG | Reference  |   |   |   |
| --- | --- | --- | --- | --- |
|  Combi Scan 500 |  | positive | negative | total  |
|   |  positive | 30 | 0 | 30  |
|   |  negative | 0 | 30 | 30  |
|   |  total | 30 | 30 | 60  |
|  SG | 1.005 | 1.010 | 1.015 | 1.020 | 1.025 | 1.030  |
| --- | --- | --- | --- | --- | --- | --- |
|  Level 1 | - | - | 10 | 20 | - | -  |
|  Level 2 | - | 22 | 8 | - | - | -  |

b. Linearity/assay reportable range:

The reportable range for each analyte is shown below:

Ascorbic acid: neg-20-40 mg/dL
Bilirubin: neg-1-2-4 mg/dL
Blood: neg-10-50-300 erythrocytes/uL
Glucose: norm-50-100-250-500-1000 mg/dL
Ketones: neg-10-25-100-300 mg/dL
Leucocytes: neg-25-75-500 leucocytes/uL
Nitrite: neg-pos
pH: 5-6-7-8-9
Protein: neg-30-100-500 mg/dL
specific gravity: 1.000-1.005-1.010-1.015-1.020-1.025-1.030
Urobilinogen: norm-2-4-8-12-mg/dL

{7}

c. Traceability, Stability, Expected values (controls, calibrators, or methods):

Stability:

No information on traceability was provided.

Test strips: The shelf life of the unopened test strips is 24 months.

Investigations were done with three lots at an age of 24, 25 and 26 months using Quantimetrix "the dipper", human urine spiked with ascorbic acid.

The performance data were verified to support the stability claim.

d. Detection limit:

The detection limit was established at concentrations where at least 50% of the observed results were positive when assayed using the Combi Scan 500. The table below presents the detection limits for each analyte on the Combi Scan 500 using the Combi-Screen 11 SYS urine test strips.

|  Parameter | Detection Limit
Combi Scan 500  |
| --- | --- |
|  Ascorbic acid | 15 mg/dL  |
|  Bilirubin | 0,6 mg/dL  |
|  Blood | 6-8 Ery/μl (as Hb.)  |
|  Glucose | 40 - 50 mg/dL  |
|  Ketones | 4 - 6 mg/dL  |
|  Leucocytes | 10 - 15 Leu/uL  |
|  Nitrite | 0,1 mg/dL  |
|  Protein | 20 mg/dL  |
|  Urobilinogen | 1,5 mg/dL  |

e. Analytical specificity:

The interference from ascorbic acid was determined using 5 patient urine samples and ascorbic acid concentrations of 0, 20, 40 and 80 mg/dL. The following were observed:

Bilirubin at 1 mg/dL (1+) and 2 mg/dL (2+):

False low or negative results were observed at 80 mg/dL of ascorbic acid.

Blood at 10, 25 and 50 Ery/uL (as Hb.):

When testing solutions with 25 Ery/uL (as Hb.) and 50 Ery/uL (as Hb.), no negative results were observed with ascorbic acid concentrations up to 80 mg/dL. When testing at 10 Ery/uL (as Hb.), 1 negative result out of 5 was

{8}

observed with both ascorbic acid concentrations of 20 and 40 mg/dL. One out of 5 was negative with both ascorbic acid concentrations of 40 and 80 mg/dL and 2 out of 5 were negative with an ascorbic acid concentration of 80 mg/dL. When testing at 25 Ery/uL (as Hb.) four out of 5 were falsely low with ascorbic acid concentration of 80 mg/dL.

Glucose at neg., 50 (1+) and 100 mg/dL (2+):
When testing glucose at 100 mg/dL with an ascorbic acid concentration of 20 mg/dL 5 out of 5 glucose results showed 1+ rather than 2+. At 40 mg/dL of ascorbic acid, 5 out of 5 glucose results for both 50 and 100 mg/dL were falsely low or negative. At 80 mg/dL of ascorbic acid, 5 out of 5 glucose results for both 50 and 100 mg/dL were falsely negative.

Nitrite negative and 0.2 mg/dL (positive):
No false negatives were observed. The sponsor cautions that a high content of ascorbic acid &gt; 80 mg/dL may lead to false negatives.

f. Assay cut-off:
Not applicable

2. Comparison studies:
a. Method comparison with predicate device:
The Combi Scan 500 was compared to the Clinitek 50 and Miditron by using 112 human urine samples. The ascorbic acid test pad is not present at the predicative devices. For that reason, the ascorbic acid test was compared to a photometric determination of ascorbic acid.

The data were evaluated by using contingency tables. In some cases, the concentration levels are not exactly the same for the Combi Scan 500, Clinitek 50 and Miditron. In these cases, the lower and higher concentrations, which are close to the mentioned concentration, were used as "same colour block". The colour blocks besides these blocks were evaluated as "+/- 1 colour block". The following agreements were observed:

{9}

|  Center | Center 1: Agreement to Clinitek 50 (Bayer) |   | Center 1: Agreement to Miditron junior (Criterion II, Roche) |   | Center 2: Agreement to Miditron (Roche) |   | Laboratory: Agreement to Clinitek 50 (Bayer)  |   |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
|  Parameter | Same colour block | +/-1 colour block | Same colour block | +/-1 colour block | Same colour block | +/-1 colour block | Same colour block | +/-1 colour block  |
|  Ascorbic acid | 84,8% * | 100% * | 84,8% * | 100% * | - | - | 100% * | 100% *  |
|  Bilirubin | 68,8% | 100% | 93,8% | 100% | 86,7% | 99,6% | 100% | 100%  |
|  Blood | 92,0% | 100% | 98,2% | 100% | 90,7% | 100% | 100% | 100%  |
|  Glucose | 86,6% | 100% | 89,3% | 100% | 90,7% | 97,8% | 93,6% | 100%  |
|  Ketones | 83,0% | 100% | 93,8% | 99,1% | 92,9% | 99,1% | 100% | 100%  |
|  Leucocyte | 83,0% | 98,2% | 91,1% | 100% | 84,1% | 99,1% | 98,4% | 100%  |
|  Nitrite | 99,1% | 100% | 96,4% | 100% | 94,7% | 100% | 100% | 100%  |
|  pH | 90,2% | 100% | 60,7% | 99,1% | 64,2% | 100% | 100% | 100%  |
|  Protein | 86,6% | 100% | 94,6% | 100% | 82,3% | 97,8% | 100% | 100%  |
|  Spec. gravity | 60,7% | 96,4% | 30,4% | 82,1% | 33,6% | 81,4% | 94,7% | 100%  |
|  Urobilinogen | 90,4% | 97,6% | 83,0% | 100% | 89,8% | 99,1% | 100% * | 100% *  |

* comparison to photometric method

b. Matrix comparison: Not applicable

3. Clinical studies:

a. Clinical Sensitivity: Not applicable
b. Clinical specificity: Not applicable
c. Other clinical supportive data (when a. and b. are not applicable): Not applicable

{10}

4. Clinical cut-off:
Not applicable

5. Expected values/Reference range:
The expected values are provided in the strip labeling from literature.

N. Instrument Name:
Combi Scan 500

O. System Descriptions:
1. Modes of Operation:
Single step or continuous testing
2. Software:
FDA has reviewed applicant’s Hazard Analysis and software development processes for this line of product types:
Yes ☐ X ☐ or No ☐
3. Specimen Identification:
The patient ID is entered manually by internal numpad, external keyboard, or external barcode reader.
4. Specimen Sampling and Handling:
The test strip is dipped into the urine manually and placed on the conveyor belt for a reading by the instrument.
5. Calibration:
There is no special calibration procedure to be carried out by the user.
6. Quality Control:
In the labeling the applicant recommends the use of external urine dipstick controls (normal + abnormal) regularly to ensure the performance of the instrument. The recommendation in the labeling states that users are to follow federal, state and local requirements for testing external quality control materials.

P. Other Supportive Instrument Performance Characteristics Data Not Covered In The “Performance Characteristics” Section above:

Q. Proposed Labeling:
The labeling is sufficient and it satisfies the requirements of 21 CFR Part 809.10.

R. Conclusion:
The submitted information in this premarket notification is complete and supports a substantial equivalence decision.

11

---

**Source:** [https://fda.innolitics.com/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/JIL/K061812](https://fda.innolitics.com/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/JIL/K061812)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com